MyFinsight
Home
Blog
About
Contact
Back
Income Statement
InMed Pharmaceuticals Inc. (INM)
InMed Pharmaceuticals Inc. (INM)
source: myfinsight.com
Download
Download image
Net loss
-$2,966,336
Net loss from
continuing operations
-$2,791,751
Loss from
discontinued operations
-$174,585
Net loss from
continuing operations...
-$2,791,751
Income (loss) from
discontinued operations
-$174,585
Interest and other income
$47,770
Total operating
expenses
$2,839,521
General and
administrative
$1,742,016
Research and development
$1,022,630
Amortization and
depreciation
$51,707
Foreign exchange loss
-$23,168
Back